Association between the CHEK2*1100delC germ line mutation and estrogen receptor status
- PMID: 17010071
- DOI: 10.1111/j.1525-1438.2006.00694.x
Association between the CHEK2*1100delC germ line mutation and estrogen receptor status
Abstract
Already published data were further analyzed regarding the association between the CHEK2*1100delC germ line mutation and estrogen receptor (ER) status in patients with breast cancer. The CHEK2*1100delC mutation was more prevalent among the patients with a positive ER status (4.2% versus 1.0%). An ER-negative status was beside CHEK2*1100delC mutation and independently associated with an earlier of age onset of breast cancer. There was a trend that an ER-negative status, beside the presence of a CHEK2*1100delC mutation, was associated with a worse disease-free survival. There might be an association between ER status and a CHEK2*1100delC mutation. More studies with larger number of patients are needed to further investigate the relation between CHEK2*1100delC and ER status.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
